Relevant bibliographies by topics / HTV 18

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'HTV 18'

Author: Grafiati
Published: 4 June 2021
Last updated: 15 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HTV 18.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HTV 18"

1

Kasahara, Toshihiko, Akira Miyauchi, Takumi Kudo, Eijun Nishihara, Mitsuru Ito, Yasuhiro Ito, Minoru Kihara, and Akihiro Miya. "Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time." Journal of Thyroid Research 2018 (2018): 1–6. http://dx.doi.org/10.1155/2018/6470251.

Full text
Abstract:
Background. Children and adolescents with papillary thyroid carcinomas (PTCs) have generally excellent prognoses despite their frequent extended disease. The tumor growth of young patients’ PTCs might show spontaneous slowing postoperatively. We compared young PTC patients’ postoperative thyroglobulin-doubling time (Tg-DT) with their preoperative hypothetical tumor volume-doubling time (hTV-DT). Methods. Fourteen PTC patients aged ≤18 years who underwent total thyroidectomy at Kuma Hospital in 1998–2016 had biochemically persistent disease postoperatively. We calculated their Tg-DTs and estimated their preoperative TV-DTs with the tumor size and the patient’s age at surgery, presuming that a single cancer cell was present at the patient’s birth. Results. Twelve patients had positive Tg-DTs ranging from 2.0 to 147 years, and the remaining two had negative Tg-DTs, indicating slow growth or even regression. The hTV-DTs were 0.3–0.6 years (median 0.5 years), which were significantly shorter than the Tg-DTs (p<0.001), indicating much faster growth preoperatively. The analyses of the nine patients without radioactive iodine administration (RAI) gave similar results (p<0.01). Conclusions. Irrespective of RAI, the patients’ postoperative Tg-DTs were significantly longer than their preoperative hTV-DTs and were negative values in two patients, indicating that the growth of these young patients’ PTCs had spontaneously slowed or even regressed postoperatively.
APA, Harvard, Vancouver, ISO, and other styles
2

Birukova, Anna A., Yufeng Tian, Angelo Meliton, Alan Leff, Tinghuai Wu, and Konstantin G. Birukov. "Stimulation of Rho signaling by pathologic mechanical stretch is a “second hit” to Rho-independent lung injury induced by IL-6." American Journal of Physiology-Lung Cellular and Molecular Physiology 302, no. 9 (May 1, 2012): L965—L975. http://dx.doi.org/10.1152/ajplung.00292.2011.

Full text
Abstract:
Most patients with acute lung injury (ALI) and acute respiratory distress syndrome of septic and nonseptic nature require assisted ventilation with positive pressure, which at suboptimal range may further exacerbate lung dysfunction. Previous studies described enhancement of agonist-induced Rho GTPase signaling and endothelial cell (EC) permeability in EC cultures exposed to pathologically relevant cyclic stretch (CS) magnitudes. This study examined a role of pathologic CS in modulation of pulmonary EC permeability caused by IL-6, a cytokine increased in sepsis and acting in a Rho-independent manner. IL-6 increased EC permeability, which was associated with activation of Jak/signal transducers and activators of transcription, p38 MAP kinase, and NF-κB signaling and was augmented by EC exposure to 18% CS. Rho kinase inhibitor Y-27632 suppressed the synergistic effect of 18% CS on IL-6-induced EC monolayer disruption but did not alter the IL-6 effects on static EC culture. 18% CS also increased IL-6-induced ICAM-1 expression by pulmonary EC and neutrophil adhesion, which was attenuated by Y-27632. Intratracheal IL-6 administration in C57BL/6J mice increased protein content and cell count in bronchoalveolar lavage fluid. These changes were augmented by high tidal volume mechanical ventilation (HTV; 30 ml/kg, 4 h). Intravenous injection of Y-27632 suppressed IL6/HTV-induced lung injury. In conclusion, this study proposes a novel mechanism contributing to two-hit model of ALI: in addition to synergistic effects on Rho-dependent endothelial hyper-permeability triggered by thrombin, TNFα, LPS, or other agonists, ventilator-induced lung injury-relevant CS may also exacerbate Rho-independent mechanisms of EC permeability induced by other inflammatory mediators such as IL-6 via mechanisms involving Rho activity.
APA, Harvard, Vancouver, ISO, and other styles
3

Rahman, Md Tahminur, Rosy Sultana, and Sohel Reza Chowdhury. "Seropositivity and pattern of viral hepatitis in clinically suspected cases of hepatitis in Dhaka city." Bangladesh Medical Research Council Bulletin 33, no. 3 (September 15, 2010): 103–6. http://dx.doi.org/10.3329/bmrcb.v33i3.1142.

Full text
Abstract:
An attempt was made to see the seropositivity and pattern of four common hepatotrophic viruses (HBV, HCV, HEV, HAV) in patients suspected to have been suffering from viral hepatitis. Blood samples from 2,995 cases of suspected HBV infection, 331 from HCV, 155 from HEV and 24 from HAV were tested for these viral markers. Of these a total of 245 (8.1%) were positive for HBsAg, 18 (5.4%) for HCV, 87 (56.1%) for HEV and 8 (33.3%) were positive for HAV infection. The predominant age group affected in HBV is 25-40 years, for HCV >61 years, HEV 26-50 years and HAV under 11 years. Seropositivity for HBsAg was statistically higher (near double) in males than females (p<0.05). HCV showed more seropositivity in males than females. HEV showed slight male preponderance and for HAV the female showed preponderance. The seropositivity rate was higher in Bangladesh in comparison to other developed and developing countries.DOI = 10.3329/bmrcb.v33i3.1142Bangladesh Med Res Counc Bull 2007; 33: 103-106
APA, Harvard, Vancouver, ISO, and other styles
4

Troisi, CL, FB Hollinger, WK Hoots, C. Contant, J. Gill, M. Ragni, R. Parmley, C. Sexauer, E. Gomperts, and G. Buchanan. "A multicenter study of viral hepatitis in a United States hemophilic population." Blood 81, no. 2 (January 15, 1993): 412–18. http://dx.doi.org/10.1182/blood.v81.2.412.412.

Full text
Abstract:
Abstract Hemophilia A and B patients seen at nine US regional treatment centers were tested for serologic markers of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) during 1987 and 1988. Because human immunodeficiency virus (HIV) infection, a potentially confounding variable, was present in 53% of the group, the population was divided by HIV status for analysis purposes. In the HIV-positive group (N = 382), less than 1% had not been infected with HBV, HCV, or HDV, whereas 75% had evidence of infection with HBV and 98% with HCV. HBsAg, a marker of active HBV infection, was present in 12% of subjects; 96% of these were HCV positive. Anti-HDV was detected in 35 subjects (9.1%); all were anti-HBc positive. Ten of the 35 (29%) also were positive for IgM anti-HDV, indicating current infection. All 10 were HBsAg positive and 7 of the 9 tested were HDV RNA positive. Severe/moderate hemophilia B patients were more likely to have experienced an HBV infection and to be anti-HDV positive than were similar hemophilia A patients (22% v 8%, P < .05). In the HIV-negative group (N = 345), the subjects were younger and had less severe hemophilia than the HIV-positive patients. No evidence of HBV, HCV, or HDV infection was found in 18%, whereas 33% had experienced HBV infection and 79% were anti-HCV positive. Within this group, 4% were HBsAg positive. All 13 subjects with anti-HDV (4% of the HIV-negative group) also possessed anti-HBc. One (7.7%) was IgM anti-HDV positive and the serum from another contained HDV RNA. Both of these individuals were HBsAg positive. As in the HIV-positive group, severe/moderate hemophilia B patients were more likely to be HBV and HDV positive than were hemophilia A patients (9% v 3%, P < .05). A prevalence study of viral hepatitis in a large US hemophilic population showed that active infection with HCV is common, occurring in 89% of all study patients regardless of HIV status. Evidence of active HBV infection was found in 8%; 19% of these were actively infected with HDV. HDV was more common in hemophilia B patients after controlling for disease severity.
APA, Harvard, Vancouver, ISO, and other styles
5

Troisi, CL, FB Hollinger, WK Hoots, C. Contant, J. Gill, M. Ragni, R. Parmley, C. Sexauer, E. Gomperts, and G. Buchanan. "A multicenter study of viral hepatitis in a United States hemophilic population." Blood 81, no. 2 (January 15, 1993): 412–18. http://dx.doi.org/10.1182/blood.v81.2.412.bloodjournal812412.

Full text
Abstract:
Hemophilia A and B patients seen at nine US regional treatment centers were tested for serologic markers of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) during 1987 and 1988. Because human immunodeficiency virus (HIV) infection, a potentially confounding variable, was present in 53% of the group, the population was divided by HIV status for analysis purposes. In the HIV-positive group (N = 382), less than 1% had not been infected with HBV, HCV, or HDV, whereas 75% had evidence of infection with HBV and 98% with HCV. HBsAg, a marker of active HBV infection, was present in 12% of subjects; 96% of these were HCV positive. Anti-HDV was detected in 35 subjects (9.1%); all were anti-HBc positive. Ten of the 35 (29%) also were positive for IgM anti-HDV, indicating current infection. All 10 were HBsAg positive and 7 of the 9 tested were HDV RNA positive. Severe/moderate hemophilia B patients were more likely to have experienced an HBV infection and to be anti-HDV positive than were similar hemophilia A patients (22% v 8%, P < .05). In the HIV-negative group (N = 345), the subjects were younger and had less severe hemophilia than the HIV-positive patients. No evidence of HBV, HCV, or HDV infection was found in 18%, whereas 33% had experienced HBV infection and 79% were anti-HCV positive. Within this group, 4% were HBsAg positive. All 13 subjects with anti-HDV (4% of the HIV-negative group) also possessed anti-HBc. One (7.7%) was IgM anti-HDV positive and the serum from another contained HDV RNA. Both of these individuals were HBsAg positive. As in the HIV-positive group, severe/moderate hemophilia B patients were more likely to be HBV and HDV positive than were hemophilia A patients (9% v 3%, P < .05). A prevalence study of viral hepatitis in a large US hemophilic population showed that active infection with HCV is common, occurring in 89% of all study patients regardless of HIV status. Evidence of active HBV infection was found in 8%; 19% of these were actively infected with HDV. HDV was more common in hemophilia B patients after controlling for disease severity.
APA, Harvard, Vancouver, ISO, and other styles
6

Prasetyo, Afiono Agung, Paramasari Dirgahayu, Yulia Sari, Hudiyono Hudiyono, and Seiji Kageyama. "Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia." Journal of Infection in Developing Countries 7, no. 06 (June 15, 2013): 453–67. http://dx.doi.org/10.3855/jidc.2965.

Full text
Abstract:
Introduction: This study was conducted to determine the current molecular prevalence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and human T lymphotropic virus-1/2 (HTLV-1/2) circulating among drug abuser inmates incarcerated in prisons located in Central Java, Indonesia. Methodology: Socio-epidemiological data and blood specimens were collected from 375 drug abuser inmates in four prisons. The blood samples were analyzed with serological and molecular testing for HIV, HBV, HCV, HDV, and HTLV-1/2. Results: The seroprevalence of HIV, HBsAg, HCV, HDV, and HTLV-1/2 in drug abuser inmates was 4.8% (18/375), 3.2% (12/375), 34.1% (128/375), 0% (0/375), and 3.7% (14/375), respectively. No co-infections of HIV and HBV were found. Co-infections of HIV/HCV, HIV/HTLV-1/2, HBV/HCV, HBV/HTLV-1/2, and HCV/HTLV-1/2 were prevalent at rates of 4% (15/375), 1.3% (5/375), 1.1% (4/375), 0.3% (1/375), and 2.1% (8/375), respectively. The HIV/HCV co-infection rate was significantly higher in injection drug users (IDUs) compared to non-IDUs. Triple co-infection of HIV/HCV/HTLV-1/2 was found only in three IDUs (0.8%). HIV CRF01_AE was found to be circulating in the inmates. HBV genotype B3 predominated, followed by C1. Subtypes adw and adr were found. HCV genotype 1a predominated among HCV-infected inmates, followed by 1c, 3k, 3a, 4a, and 1b. All HTLV-1 isolates shared 100% homology with HTLV-1 isolated in Japan, while all of the HTLV-2 isolates were subtype 2a. Conclusion: Drug abuser inmates in prisons may offer a unique community to bridge prevention and control of human blood-borne virus infection to the general community.
APA, Harvard, Vancouver, ISO, and other styles
7

Nikonorova, Marina A., N. S. Lubskaya, E. V. Volchkova, E. A. Nemilostiva, and O. I. Matros. "VARIANTS OF THYROID GLAND PATHOLOGY IN CHRONIC HEPATITIS C PATIENTS." Epidemiology and Infectious Diseases 22, no. 4 (August 15, 2017): 172–77. http://dx.doi.org/10.17816/eid40958.

Full text
Abstract:
Introduction. HCV is the cause not only of cirrhosis, hepatocellular carcinoma, but also extrahepatic manifestations. Currently, HCV is considered as an independent risk factor for thyroid pathology. In recent years, the level of pathology of the thyroid gland in the Altai Territory has increased by 16.4 times, which determined the purpose of this study: to study the features of the thyroid status in patients with chronic hepatitis C (CHC) in the Altai Territory. Materials and methods. There was executed a prospective, dynamic clinical, laboratory and instrumental examination of 240 CHC patients (47,5% of men and 52,5% of women aged of from 18 to 50 years), 120 of whom had HCV (49,1% of men and 50,9% of women, aged of from 18 to 50 years, mean age: 41,1±9,91 years) who did not receive antiviral therapy (HTV), the pathology of the thyroid gland in them was established for the first time. The study included the assessment of the level of TSH, total and free T3, T4, antibodies to thyreperoxidase (APPO), ultrasound examination of the thyroid gland. The diagnosis of CHC is based on HCV RNA, anti-HCV (core, NS3-5), blood biochemistry, fibrosis level score according to Metavir (elastometry, PBP). Results of the study. In HCV patients there were revealed autoimmune thyroiditis (AIT) (5%), AIT with hypothyroidism (10%), AIT with latent hypothyroidism (8,3%), latent hypothyroidism (10%), hypothyroidism (16,6%), euthyroidism (49,1%) and thyrotoxicosis in only 1 patient. Variants of thyroid dysfunction were presented in the form of euthyroidism (60%), hypothyroidism (20%), hyperthyroidism (10%) and autoimmune thyroiditis (10%). The relationship between the development of the thyroid dysfunction (TD) and the history of the history of HCV infection has been established. Discussion and conclusions. CHC patients were more likely to have a history of euthyroidism and hypothyroidism. The relationship between TD and the duration of HCV infection can be regarded as its extrahepatic manifestation, and not as comorbid conditions. Thorough examination of the thyroid status it makes possible to identify TD people, which can be reflected in the choice of antiviral therapy and will determine the prognosis of the development of side effects.
APA, Harvard, Vancouver, ISO, and other styles
8

Ramezani, A., M. Mohraz, A. Aghakhani, M. Banifazl, A. Eslamifar, A. Khadem-Sadegh, and A. A. Velayati. "Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals." International Journal of STD & AIDS 20, no. 5 (May 2009): 336–38. http://dx.doi.org/10.1258/ijsa.2008.008377.

Full text
Abstract:
Association between isolated hepatitis B core antibody (anti-HBc) and hepatitis C virus (HCV) infection has been noted in HIV-infected individuals. This study describes the frequency of isolated anti-HBc and its possible value for the detection of HBV-DNA in HIV-infected patients with or without HCV co-infection. Ninety-two HIV-infected patients were enrolled in the study. Hepatitis B surface antigen (HBs Ag), anti-HBs, anti-HBc, anti-HCV, HIV viral load and CD4 count were tested in all subjects. Then we compared 63 subjects with HIV-HCV co-infection with 29 subjects with HIV infection alone regarding isolated anti-HBc (HBs Ag negative, anti-HBs negative and anti-HBc positive). The presence of HBV-DNA was determined by real-time polymerase chain reaction in serum samples of patients with isolated anti-HBc. Of 63 anti-HCV-positive patients, 18 subjects (28.6%, 95% [confidence interval] CI: 22.6–34.6%), and of 29 anti-HCV-negative patients, five subjects (17.2%, 95% CI: 11.5–22.9%) had isolated anti-HBc. HBV-DNA was detectable in three of 18 anti-HCV-positive patients (16.7%, 95% CI: 9.7–23.7%) and none of the anti-HCV-negative patients with isolated anti-HBc. Our study showed that individuals co-infected with HIV and HCV were more likely to have isolated anti-HBc than subjects with HIV alone. This investigation also demonstrates that the presence of isolated anti-HBc in HIV-HCV-infected individuals may reflect occult HBV infection in these patients.
APA, Harvard, Vancouver, ISO, and other styles
9

Bakhti, Mehrnaz, Mohammadreza Haghshenas, Reza Valadan, and Mehdi Rabie Rudsari. "Prevalence of HBV/HCV Infections in HIV-Positive Patients in Northern Iran." Research in Molecular Medicine 5, no. 4 (October 10, 2018): 61. http://dx.doi.org/10.18502/rmm.v5i4.3066.

Full text
Abstract:
Introduction: Human immunodeficiency virus (HIV) infection increases the risk of infection with other pathogens, including hepatitis B virus (HBV) and hepatitis C virus (HCV). A crucial aspect of HIV prevention and treatment programs is knowledge of the prevalence of co-infection of HIV and HBV and/or HCV. This study sought to determine HBV and HCV co-infection in HIV-positive patients in northern Iran. Materials and Methods: Blood samples were collected from 83 HIV-positive patients whose infection was previously confirmed by real-time polymerase chain reaction in the HIV center in the North of Iran. A structured questionnaire was used to obtain socio-demographic data from participants. Samples were screened for hepatitis B surface antigen and anti-HCV antibody. All non-reactive samples were recorded as negative. Results: The 83 patients comprised 50 (60%) males and 33 (40%) females. Twenty eight (33%) and 15 (18%) subjects were positive for HCV antibody and hepatitis B surface antigen, respectively. Seven (8%) of subjects were co-infected with all three viruses. Conclusion: Seroprevalence of HCV and HIV co-infection was high and was strongly related to mutual acquisition.
APA, Harvard, Vancouver, ISO, and other styles
10

STARK, K., U. HERRMANN, S. EHRHARDT, and U. BIENZLE. "A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany." Epidemiology and Infection 134, no. 4 (December 22, 2005): 814–19. http://dx.doi.org/10.1017/s0950268805005613.

Full text
Abstract:
In two prisons in Berlin, Germany, provision of sterile injection equipment for injecting drug users (IDUs) started in 1998. To assess the programme's impact, the frequency of injecting drug use and syringe sharing, and the incidence of HIV, HBV, and HCV infection were determined in a follow-up study. Of all IDUs (n=174), 75% continued to inject. After the project start the level of syringe sharing declined from 71% during a 4-month period of previous imprisonment to 11% during the first 4 months of follow-up, and to virtually zero thereafter. Baseline seroprevalences for HIV, HBV, and HCV were 18, 53, and 82%. HIV and HCV seroprevalence at baseline was significantly associated with drug injection in prison prior to the project start. No HIV and HBV seroconversions, but four HCV seroconversions occurred. The provision of syringes for IDUs in appropriate prison settings may contribute to a substantial reduction of syringe sharing. However, the prevention of HCV infection requires additional strategies.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HTV 18"

1

Chalupa, Pavel. "Pevnostní kontrola nákladního přívěsu HTV 18." Master's thesis, Vysoké učení technické v Brně. Fakulta strojního inženýrství, 2014. http://www.nusl.cz/ntk/nusl-231490.

Full text
Abstract:
The subject of this master's thesis is the strength analysis of the cargo trailer HIPOCAR HTV 18 and proposed modifications. For the strength analysis was selected finite element method. The frame model was modified by the results of the strength analysis. After that has been carried out the strength analysis of the modified frame.
APA, Harvard, Vancouver, ISO, and other styles
2

AZEVEDO, Karinne Silva. "Avaliação da prevalência do Papíloma Humano (HPV) em saliva de pacientes portadores do HIV." Universidade Federal de Pernambuco, 2015. https://repositorio.ufpe.br/handle/123456789/18071.

Full text
Abstract:
Submitted by Fabio Sobreira Campos da Costa (fabio.sobreira@ufpe.br) on 2016-12-12T14:11:56Z No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) DISSERTACAO PARA BIBLIOTECA CENTRAL - KARINNE AZEVEDO.pdf: 2052240 bytes, checksum: fba514c37249c7db73fcf51a37fa21ff (MD5)
Made available in DSpace on 2016-12-12T14:11:56Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) DISSERTACAO PARA BIBLIOTECA CENTRAL - KARINNE AZEVEDO.pdf: 2052240 bytes, checksum: fba514c37249c7db73fcf51a37fa21ff (MD5) Previous issue date: 2015-08-27
CAPES
Identificar a presença dos sorotipos de alto risco do Papilomavírus Humano (HPV) na saliva de pacientes portadores do vírus HIV. A amostra de 90 pacientes foi oriunda de dois centros de referência em tratamento de ISTs da cidade do Recife, PE, Brasil. Uma entrevista foi realizada para identificar o perfil da amostra, sendo realizada uma coleta de saliva empregando tubos falcon e solução para bochecho com sacarose a 5%, com posterior armazenamento em freezer a -20°C para rastreamento do HPV e genotipagem para o sorotipo 16 e 18 por PCR convencional. Na amostra predominou a presença do sexo masculino 59 de 90 (65,6%), com idade média de 38,8 anos, variando entre 18 e 69 anos, renda familiar média de 1,95 Salários Mínimos (DP = 1,37). A prevalência de HPV nesta amostra foi de 23 de 90 (25,6%) e dos sorotipos 16 e 18 foi 8 de 90 (8,9%). A co-infecção por HPV é comumente observada em pacientes portadores de HIV.
To identify the presence of high-risk serotypes human papillomavirus (HPV) in patients with sexually transmitted infections (STIs). A sample of 90 patients were from two referral hospitals in treatment of STIs. An interview was conducted to identify the sample’s profile a saliva collections being perfomed using falcon tubs and mount rinse with 5% sucrose, subsequente storage in a freezer at -20ºC for HPV screening and genotyping for serotype 16 and 18 by conventional PCR. In the sample predominant male presence 59 of 90 (65.6%) with mean age of 38.8 years, ranging between 18 and 69 years, average family income of 1.95 minimum wages (SD = 1, 37). The prevalence of HPV in this sample was 23 of 90 (25.6%) and the serotype HPV 16 and 18 was 8 of 90 (8.9%). Co-infection with HPV is commonly observed in HIV patients.
APA, Harvard, Vancouver, ISO, and other styles
3

Corden, Sally Anne. "HPV-18 DNA integration in cervical cancer." Thesis, University of Warwick, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.267050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tsuda, Luciana Castelar. "Polimorfismos do fator de necrose tumoral alfa, da interleucina-18 e do interferon gama na coinfecção HIV/HCV." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/22/22132/tde-23112015-192335/.

Full text
Abstract:
As complicações hepáticas secundárias à infecção crônica pelo vírus da hepatite C (HCV) são uma importante causa de morte em portadores da infecção pelo vírus da imunodeficiência humana (HIV). Pacientes com coinfecção HIV/HCV apresentam progressão acelerada da fibrose hepática, na qual há participação da resposta inflamatória do sistema imunológico, e requerem maior atenção no tratamento da hepatite C e de suas reações adversas. Assim, os objetivos principais do estudo foram tipificar e comparar os polimorfismos -607 e -137 da interleucina-18 (IL-18), +874 do interferon gama (IFN-?? e -308 e -238 do fator de necrose tumoral alfa (TNF- ?? em quatro grupos (coinfecção HIV/HCV, monoinfecção pelo HIV, monoinfecção pelo HCV e controles saudáveis); investigar a associação dos alelos e genótipos desses polimorfismos com a resposta ao tratamento da hepatite C (respondedor e não respondedor), graus de atividade necroinflamatória (METAVIR A0A1 vs. A2A3) e de fibrose hepática (METAVIR F0-F2 vs. F3F4) em portadores do HCV e identificar os sinais e sintomas relacionados às reações adversas do tratamento da hepatite C. Os dados foram coletados nos prontuários médicos e no sistema informatizado do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto e os polimorfismos tipificados pela técnica de reação em cadeia da polimerase com iniciadores de sequência específica. Participaram do estudo 400 indivíduos, distribuídos em quatro grupos de 100, predominantemente constituídos por homens com idade média entre 33 e 50 anos. Na avaliação geral, os genótipos -238 G/G (TNF-?? e +874 A/A (IFN-?? foram mais frequentes no grupo coinfecção HIV/HCV em relação ao monoinfecção pelo HCV. O genótipo -308 G/A e o alelo -308 A (TNF-?? foram associados com a susceptibilidade à coinfecção HIV/HCV e o genótipo -308 G/G e o alelo -308 G (TNF-?), com proteção. No grupo coinfecção HIV/HCV, a frequência do genótipo - 137 G/C (IL-18) foi maior nos sujeitos com atividade necroinflamatória A0A1 que nos com A2A3. Nos pacientes com fibrose F3F4, o genótipo -238 G/G (TNF-?? foi mais frequente no grupo coinfecção HIV/HCV que no monoinfecção pelo HCV e naqueles com F0-F2, o genótipo +874 A/A (IFN-?? também foi mais frequente no grupo coinfecção HIV/HCV. A frequência do genótipo +874 T/T (IFN-??, dentre os pacientes do grupo coinfecção HIV/HCV, foi maior naqueles com fibrose F3F4 que nos com F0-F2. Não foram encontradas associações estatisticamente significantes entre as frequências alélicas e genotípicas e os tipos de resposta ao tratamento da hepatite C nos pacientes do grupo coinfecção HIV/HCV; nos do monoinfecção pelo HCV, houve diferenças nas frequências alélicas e genotípicas (posição -238 do TNF-?) entre pacientes respondedores e não respondedores. Os principais sinais e sintomas relacionados às reações adversas do tratamento da hepatite C foram mialgia, febre, fraqueza, cefaleia e hiporexia. Anemia, hiporexia e vômito foram mais frequentes no grupo coinfecção HIV/HCV. Conclui-se que há relação dos alelos e genótipos de citocinas com a gravidade da doença hepática e resposta ao tratamento da hepatite C. Adicionalmente, algumas reações adversas ao tratamento foram mais pronunciadas em coinfectados HIV/HCV
Hepatic complications secondary to chronic infection by hepatitis C virus (HCV) are a major cause of death in people infected by the human immunodeficiency virus (HIV). Patients with HIV/HCV coinfection present rapid progression of liver fibrosis, with involvement of the immune system\'s inflammatory response, and require more attention in hepatitis C treatment and its adverse reactions. The main goals of this study were to typify and compare the polymorphisms -607 and -137 of the interleukin-18 (IL-18), +874 of the interferon gamma (IFN-?? and -308 and -238 of the tumor necrosis factor-alpha (TNF-?? in four groups (HIV/HCV coinfection, HIV monoinfection, HCV monoinfection and healthy controls), to investigate the association of the alleles and genotypes of these polymorphisms with response to hepatitis C treatment (responder and non-responder), degrees of necroinflammatory activity (METAVIR A0A1 vs. A2A3) and of liver fibrosis (METAVIR F0-F2 vs. F3F4) in HCV patients and to identify the signs and symptoms related to adverse reactions of hepatitis C treatment. Data were collected on medical records and on the computerized system of the Hospital das Clínicas of the University of São Paulo Ribeirão Preto Medical School and the polymorphisms were typified using the polymerase chain reaction technique with sequence specific primers. The study included 400 individuals, distributed in four groups of 100, predominantly consisting of men with an average age between 33 and 50 years. In the overall evaluation, genotypes -238 G/G (TNF-?? and +874 A/A (IFN-?? were more frequent in the HIV/HCV coinfection group compared to HCV monoinfection. The genotype -308 G/A and allele -308 A (TNF-?? were associated with susceptibility to HIV/HCV coinfection and the genotype -308 G/G and allele -308 G (TNF-?), with protection. In the HIV/HCV coinfection group, the frequency of genotype -137 G/C (IL-18) was greater in subjects with necroinflammatory activity A0A1 than in the ones with A2A3. In patients with fibrosis F3F4, genotype -238 G/G (TNF-?? was more frequent in the HIV/HCV coinfection than in the HCV monoinfection group and in those with fibrosis F0-F2, genotype +874 A/A (IFN-?? was also more frequent in the HIV/HCV coinfection group. The frequency of genotype +874 T/T (IFN-??, among patients of the HIV/HCV coinfection group, was higher in those with fibrosis F3F4 compared to the ones with F0-F2. No statistically significant associations were found between the allele and genotype frequencies and the types of answer to hepatitis C treatment in patients of the HIV/HCV coinfection group. On the ones of the HCV monoinfection group, there were differences on the allele and genotype frequencies (position -238 of TNF-?? among responder and non-responder patients. The main signs and symptoms related to adverse reactions to hepatitis C treatment were myalgia, fever, weakness, headache and loss of appetite. Anemia, loss of appetite and vomiting were more frequent in the HIV/HCV coinfection group. It is concluded that there is relationship of the alleles and genotypes of cytokines with the severity of liver disease and response to hepatitis C treatment. Additionally, some adverse reactions to treatment were more frequent in HIV/HCV coinfected patients
APA, Harvard, Vancouver, ISO, and other styles
5

Colomb, Julie. "Synthèse et radiomarquage de ligands des récepteurs sérotoninergiques 5-HT6 et 5-HT7 pour la tomographie par émission de positons." Thesis, Lyon 1, 2013. http://www.theses.fr/2013LYO10173/document.

Full text
Abstract:
Le développement de radiotraceurs (18F) des récepteurs de la sérotonine 5-HT6 et 5-HT7 pour l'imagerie TEP (tomographie par émission de positons) permettrait d'étudier la fonction et l'implication de ces récepteurs dans des maladies neurodégénératives telles que la schizophrénie ou la maladie d'Alzheimer. A partir des structures et pharmacophores déjà décrits dans la littérature, nous nous sommes orientés vers des dérivés pyrrolidiniques pour les récepteurs 5-HT7 et quinolines pour les récepteurs 5-HT6. 7 radioligands des récepteurs 5-HT7 marqués au fluor 18 ont pu être étudiés par autoradiographie et imagerie μTEP sur le rat et ont montrés des fixations intéressantes, mais avec une sélectivité moyenne du récepteur. 16 ligands du récepteur 5-HT6 ont été synthétisés et 4 d'entre eux ont été radiomarqués afin d'identifier le 2FNQ1P comme radioligand sélectif vis-à-vis du récepteur 5-HT2A (principal récepteur en compétition). Les premières images TEP réalisées sur le chat ont montrées un marquage sélectif dans les zones cérébrales riches en 5-HT6. La poursuite des études biologiques menées en collaboration avec le CERMEP – Imagerie du vivant permettront d'approfondir les caractéristiques de ces nouveaux radioligands synthétisés
Development of fluorine 18 labeled radiotracer of 5-HT6 and 5-HT7 receptors for PET imaging (positron emission tomography) allows the study of those receptors in various neurodegenerative diseases such as schizophrenia and Alzheimer disease. Description of structures and pharmacophores in literature led to pyrrolidine derivatives for 5-HT7 receptors and quinolones for 5-HT6. After their synthesis, 7 radioligands of 5-HT7 receptors have been studied by autoradiography and μPET. These radioligands have shown interesting binding on rat, with more or less selectivity for the receptor. 14 ligands of 5-HT6 receptors have been synthesized and 4 have been radiolabeled to select 2FNQ1P as a selective radioligand toward 5-HT2A. First PET images on cat have shown a selective binding in 5- HT6 rich area in brain. Pursue of biological studies, in collaboration with CERMEP – Imagerie du vivant will give more information on those new radioligands
APA, Harvard, Vancouver, ISO, and other styles
6

Schlottmann, Renate. "Zirkulierendes Interleukin-18 im Verlauf der HIV-Infektion und HIV-Hepatitis B- und C-Koinfektion." [S.l.] : [s.n.], 2004. http://deposit.ddb.de/cgi-bin/dokserv?idn=97450727X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wong, Ting-yin, and 王婷妍. "HPV 16 and HPV 18 detection in cytology sample of follicular cervicitis using LAMP assay." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46632761.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lautenschläger, Philine. "Konzepte der Leidenschaft : Phädra-Vertonungen im 18. Jahrhundert und das Gattungssystem der tragischen Oper /." Schliengen : Edition Argus, 2008. http://www.editionargus.de/pd1218803042.htm.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Leung, Sze-ki, and 梁詩琪. "Mechanism of human immunodeficiency virus induced immunedysregulation: TAT & IL-18 interaction." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B34605472.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Correr, Wagner Rafael. "Development of impedimetric DNA sensor for diagnosis of Human Papillomavirus type 18 infection." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-05032015-144417/.

Full text
Abstract:
Currently, the most common strategy employed to detect DNA sequences is PCR (Polymerase Chain Reaction). Nevertheless, in the last few years research on DNA biosensors has increased significantly. Such sensors represent an alternative to PCR in the detection of specific DNA sequences, once they exhibit fast response, low limits of detection, and require simpler sample preparation. The development of a biosensor for detection of DNA from Human Papillomavirus type 18 is reported. To immobilise DNA probe onto indium-tin oxide (ITO) electrodes, a silanisation was carried out using 3-Aminopropyltryethoxysilane (APTES). Silanisation was studied and optimised using ultra-violet absorption spectroscopy, atomic force microscopy, fluorescence microscopy, and cyclic voltammetry. After immobilisation, the hybridisation with target sequence is detected by changes in surface properties of ITO electrode by Cyclic Voltammetry and Electrochemical Impedance Spectroscopy, using the Ferri-Ferrocyante redox couple. The detection of synthetic target sequence was performed in the range of 12.5 to 100 nM, and 300nM for PCR products. The sensor did not show significative response for non-complementary sequence at 50 nM. This sensor can be applied for fast and low cost detection of HPV genetic material at nanomolar levels.
A estratégia mais empregada atualmente na detecção de sequência de DNA é a PCR (Reação em Cadeira da Polimerase). Contudo, nos últimos anos, a pesquisa em biossensores de DNA tem aumentado significativamente. Estes sensores representam uma alternativa a PCR na detecção de sequências específicas de DNA, uma vez que exibem resposta rápida, baixos limites de detecção e requerem preparação simples da amostra. Nesta dissertação descrito o desenvolvimento de um biossensor para a detecção do DNA do Papilomavirus Humano tipo 18. A fim de imobilizar a sequência de captura de DNA em eletrodos de óxido de estanho e índio (ITO), realizou-se uma silanização usando 3-Aminopropiltrietoxisilano (APTES). A reação de silanização foi estudada e otimizada através das técnicas de Espectroscopia de Absorção Ultravioleta, Microscopia de Força Atômica, Microscopia de Fluorescência e Voltametria Cíclica. Após a imobilização, a hibridização com a sequência alvo é detectada através de alterações nas propriedades de superfície do eletrodo através de Voltametria Cíclica e Espectroscopia de Impedância Eletroquímica, usando o par redox Ferri-ferrocianeto. A detecção da sequência alvo sintética foi realizada no intervalo de 12.5 a 100 nM, e para o produto de PCR, 300 nM. O sensor não demonstrou resposta significativa para sequência não complementar a 50 nM. Este sensor pode ser aplicado na detecção rápida e de baixo custo de material genético do HPV a níveis nanomolares.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HTV 18"

1

Regional Orientation Workshop on HIV/AIDS (2002 Addis Ababa, Ethiopia). Regional Orientation Workshop on HIV/AIDS, 18-22 November 2002. Addis Ababa, Ethiopia: UNFRA CSTAA, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

CRDA Workshop (1992 Addis Ababa, Ethiopia). CRDA Workshop: "HIV/AIDS in children", March 18-19, 1992. Addis Ababa, Ethiopia: CRDA, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Regional, Orientation Workshop on HIV/AIDS (2002 Addis Ababa Ethiopia). Regional Orientation Workshop on HIV/AIDS, 18-22 November 2002. Addis Ababa, Ethiopia: UNFRA CSTAA, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Regional Orientation Workshop on HIV/AIDS (2002 Addis Ababa, Ethiopia). Regional Orientation Workshop on HIV/AIDS, 18-22 November 2002. Addis Ababa, Ethiopia: UNFRA CSTAA, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

European Conference on Experimental AIDS Research (4th 1999 Tampere, Finland). The Fourth European Conference on Experimental AIDS Research: Tampere, Finland, June 18-21, 1999. Bologna: Monduzzi Editore, International Proceedings Division, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

International Workshop on HDTV (4th 1992 Kawasaki, Japan). Signal processing of HDTV, IV: Proceedings of the International Workshop on HDTV '92, Kawasaki, Japan, November 18-20, 1992. Amsterdam: Elsevier, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fonn, Sharon. Informing research on HIV prevention: A consultation, 16-18 September 1998, Johannesburg, South Africa. New York: Population Council, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Management), National HIV &. AIDS Research and Best Practices Conference (2005 Malawi Institute of. National HIV & AIDS Research and Best Practices Conference: Malawi Institute of Management, 18-20 April 2005. Lilongwe: National AIDS Commission, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Regional, Training Workshop on the HIV/AIDS on the Elderly (1998 Bombay India). Report of the Regional Training Workshop on the Impact of HIV/AIDS on the Elderly, September 14-18, 1998, Hotel Heritage, Mumbai. Mumbai: Tata Institute of Social Sciences, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lokakarya Issue Sosial dan Perilaku Dalam Penanganan HIV/AIDS di Indonesia (1997 Jakarta, Indonesia). Prosiding Lokakarya Issue Sosial dan Perilaku Dalam Penanganan HIV/AIDS di Indonesia, Jakarta, 18-19 Februari 1997. [Jakarta]: Puslitbang Kependudukan dan Ketenagakerjaan, Lembaga Ilmu Pengetahuan Indonesia, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HTV 18"

1

Bothe, V., and A. M. Mingers. "Laborbefundvergleiche zwischen HIV-infizierten und nicht HIV-infizierten Patienten mit schwerer Hämophilie." In 18. Hämophilie-Symposion Hamburg 1987, 82–90. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Scharrer, I. "Thrombozytopenie bei HIV-1-Infektionen." In 18. Hämophilie-Symposion Hamburg 1987, 51–56. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

ITA, OEAW. "HTA-Newsletter Juni 2003/Nr. 18." In ITA - Elektronische Publikationen, ITA—ht—0503. Wien: Verlag der Österreichischen Akademie der Wissenschaften, 2003. http://dx.doi.org/10.1553/ita-ht-0503.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schneweis, K. E. "Virologische Untersuchungen bei HIV-seropositiven Hämophilen." In 18. Hämophilie-Symposion Hamburg 1987, 29–34. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rister, M., M. Suttorp, and U. Siegel. "Granulozytenfunktion bei HlV-infizierten Hämophilie-Patienten." In 18. Hämophilie-Symposion Hamburg 1987, 145–48. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bergmann, L. "Therapeutische Immunmodulation bei der HIV-Infektion?" In 18. Hämophilie-Symposion Hamburg 1987, 193–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Goebel, F. D. "Chemotherapeutische Hemmung der HIV-1 -Replikation." In 18. Hämophilie-Symposion Hamburg 1987, 200–206. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Seifried, E., G. Pindur, D. Ellbrück, and G. Gaedicke. "Immunthrombozytopenie bei HIV-Infektion und Hämophilie A." In 18. Hämophilie-Symposion Hamburg 1987, 62–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Von Kries, R. "Thrombozytopenie bei einem 12jährigen HIV-positiven Hämophilen." In 18. Hämophilie-Symposion Hamburg 1987, 77–81. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Eibl, H. "Informationen zum Stand der HIV-1-Impfstoffentwicklung." In 18. Hämophilie-Symposion Hamburg 1987, 93–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73589-9_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HTV 18"

1

Lawrence, Tom M., and Marvin D. Kemple. "Use of Programmed Piezo Crystal Flexures for Economic Vapor Deposition of Parylene HT® on Unlimited Lengths of Magnet Wire." In ASME 2018 13th International Manufacturing Science and Engineering Conference. American Society of Mechanical Engineers, 2018. http://dx.doi.org/10.1115/msec2018-6321.

Full text
Abstract:
The electronics industry recognizes the need for high-temperature electronics (HTE) particularly for aerospace and geothermal applications. HTE is generally defined as robust operation in temperatures up to 300°C. A major constraint to HTE is high temperature magnet wire which is pervasive in electronic component windings and signal wire for sensors. The magnet wire constraint is caused by the temperature limits of the thin Polytetrafluoroethylene (PTFE) and Fluorinated Ethylene Propylene (FEP) coatings applied to HT magnet wire that limits the operating temperature to 220°C. [1], [2] There are coatings, particularly parylene-based coatings such as parylene HT®, that would greatly improve HT magnet wire, signal wire, and create the potential for subminiature thermocouple (TC) sensors; however, the slow vapor deposition process required to apply parylene is generally thought impractical for use in pore-free coating of long lengths of small diameter wire. For this research, experiments were first performed coating small diameter, wire product prototypes in standard batch vacuum chambers utilizing static fixtures. Finding this approach impractical we devised a new process utilizing a piezo-crystal electrodynamically actuated fixture of 14” diameter by 18” height that supports a web of one 24,500’ long, continuous small-diameter wire. A prototype dynamic fixture was built and a trial run successfully coated a 1500’ length of 0.005” diameter copper wire with Parylene HT®. This successful demonstration was the basis for a DOL Phase I SBIR to explore the feasibility of electrodynamically actuated devises that would synchronize horizontal and vertical actuation to drive horizontal motion to the wire web to enable a continuous reel-to-reel operation for parylene vapor deposition. This is discussed in future work.
APA, Harvard, Vancouver, ISO, and other styles
2

Levy, Jay A. "Abstract IA36: HIV, HTLV, and EBV infection and the development of cancer." In Abstracts: AACR International Conference: New Frontiers in Cancer Research; January 18-22, 2017; Cape Town, South Africa. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.newfront17-ia36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cheng, Ya-Wen, and Nan-Yung Hsu. "Abstract 1187: Inactivation of p53 in HPV-infected lung cancer is correlated with p53 codon 72 genotypes and HPV 16/18 E6 protein expression but not with HPV 16/18 DNA." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1187.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brim, Hassan, Ali Afsari, Nazli Atefi, Nicole Retland, Muneer Abbas, Tammey Naab, Babak Shokrani, et al. "Abstract 5056: HPV, HIV and male gender as major risk factors for anal neoplastic transformation in African Americans." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wagner, A., R. Richter, JP Siedentopf, W. Henrich, E. Taube, AM Kaufmann, and I. Rohr. "High-risk HPV DNA genotyping for primary cervical cancer screening compared with cytology and colposcopy in HIV-positive women: preliminary results." In 62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe – DGGG'18. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1671328.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jindal, Gagan, and Yuting Liao. "Living with HIV/AIDS." In SMSociety '18: International Conference on Social Media and Society. New York, NY, USA: ACM, 2018. http://dx.doi.org/10.1145/3217804.3217937.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Eggersmann, T., C. Thaler, C. Dannecker, S. Mahner, K. Weyerstahl, T. Weyerstahl, F. Bergauer, and J. Gallwas. "Prevalence of oral HPV infection in cervical HPV positive women." In 62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe – DGGG'18. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1671068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ghatol, Abhijeet, and Nikhil Barot. "A Case Of Human Herpes Virus 8 (HHV 8)-Associated Extracavitary Lymphoma In A Patient With Disseminated Kaposi Sarcoma And HIV." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2970.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lusher, J. M., L. M. Aledort, S. Sarnaik, and J. Mosley. "HIV STATUS, T CELL SUBSETS, BLOOD PRODUCT USE, AND HEMATOLOGIC ABNORMALITIES IN CONGENITAL COAGULATION DISORDERS (CCD)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644681.

Full text
Abstract:
Data are presented on 485 subjects with CCDtreated with blood products at entry into a cooperative study of blood product safety; 376 subjects had hemophilia A, 86 had hemophilia B,and 23 had von Willebrand*is disease (vWD) . Anti-HIV was detected in a total of 323 (66.7%)subjects. Of those treated with pooled product303/397 (76.4%) had anti-HIV; of these, 256/316 (81%) had hemo. A, 44/76 (57.9%) had hemo. B, and 3/5 (60%) had vWD. Of those treated withunpooled products 20/88 (22.7%) had anti-HIV;of these 17/60 (28.3%) had hemo. A; 0 of 10 hadhemo. B, and 3/18 (16.6%) had vWD.The percent of T4 cells in all groups studied were significantly lower in anti-HIV (+) as compared toanti-HIV (-) patients (26% vs 42%) (p=0.0001).T4/T8 ratios demonstrated significant differences in all groups treated (p=0.001) when comparing anti-HIV (+) with anti-HIV (-). However, F VIII concentrate recipients who are anti-HIV(-) have significantly lower T4/T8 when compared to controls (p=0.0001) and single pooled F VIII deficient recipient patients (p=0.0264). Mean platelet counts, WBC, ALC, and Hgb were all significantly lower in anti-HIV ( + ) subjects (p <.001,=.0002,=.002, and =.02) A significantly higher % of anti-HIV (+) subjects had abnormally low WBC, ALC and platelet counts (table). In summary, anti-HIV (+) and lower T4/T8ratios were related to type of blood product used, being seen significantly less frequently in patients receiving only unpooled product. Thrombopenia, leucopenia, and lymphopenia were seen more frequently in anti-HIV (+) patients. _
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Y., and H. Chen. "EP432 HPV 18 predicts worse prognosis in patients with cervical cancer treated with chemoradiotherapy." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.491.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HTV 18"

1

Hay, M. S., C. J. Coleman, and D. P. Diprete. Analysis of Tank 30H (HTF-30-18-96, -97), Tank 32H (HTF-32-18-98, -99), and Tank 37H (HTF-37-18-100, -101) Samples for Support of the Evaporator Feed Qualification and Corrosion Control Programs for the 3H-Evaporator. Office of Scientific and Technical Information (OSTI), January 2019. http://dx.doi.org/10.2172/1491792.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hay, M. S., C. J. Coleman, and D. P. Diprete. Analysis of Tank 30H (HTF-30-18-54, -55), Tank 32H (HTF-32-18-56, -57), and Tank 37H (HTF-37-18-58, -59) Samples for Support of the Evaporator Feed Qualification and Corrosion Control Programs for the 3H-Evaporator. Office of Scientific and Technical Information (OSTI), August 2018. http://dx.doi.org/10.2172/1469280.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hay, M. S., C. J. Coleman, and D. P. Diprete. Analysis of Tank 38H (HTF-38-18-43, -44) and Tank 43H (HTF-43-18-41, -42) Samples for Support of the Enrichment Control and Corrosion Control Programs. Office of Scientific and Technical Information (OSTI), June 2018. http://dx.doi.org/10.2172/1459416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hay, M. S., C. J. Coleman, and D. P. Diprete. Analysis of Tank 38H (HTF-38-18-43,-44) and Tank 43H (HTF-43-18-41, -42) Samples for Support of the Enrichment Control and Corrosion Control Programs. Office of Scientific and Technical Information (OSTI), July 2018. http://dx.doi.org/10.2172/1463288.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hay, M. S., C. J. Coleman, and D. P. Diprete. Analysis of Tank 38H (HTF-38-18-78, -79) and Tank 43H (HTF-43-18-80, -81, -83) Samples for Support of the Enrichment Control and Corrosion Control Programs. Office of Scientific and Technical Information (OSTI), November 2018. http://dx.doi.org/10.2172/1485266.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hay, M. S., C. J. Coleman, and D. Diprete. Analysis of Sludge Batch 10 Samples from Tank 51H (HTF-51-18-94, -95). Office of Scientific and Technical Information (OSTI), March 2019. http://dx.doi.org/10.2172/1504626.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bruce, Judith, and Shelley Clark. The implications of early marriage for HIV/AIDS policy. Population Council, 2004. http://dx.doi.org/10.31899/pgy22.1000.

Full text
Abstract:
This brief is based on a background paper prepared for the WHO/UNFPA/Population Council Technical Consultation on Married Adolescents, held in Geneva, Switzerland, December 9–12, 2003. The final paper is entitled “Including married adolescents in adolescent reproductive health and HIV/AIDS policy.” The consultation brought together experts from the United Nations, donors, and nongovernmental agencies to consider the evidence regarding married adolescent girls’ reproductive health, vulnerability to HIV infection, social and economic disadvantage, and rights. The relationships to major policy initiatives—including safe motherhood, HIV, adolescent sexual and reproductive health, and reproductive rights—were explored, and emerging findings from the still relatively rare programs that are directed at this population were discussed. Married adolescent girls are outside the conventionally defined research interests, policy diagnosis, and basic interventions that have underpinned adolescent reproductive health programming and many HIV/AIDS prevention activities. They are an isolated, often numerically large, and extremely vulnerable segment of the population, largely untouched by current intervention strategies. As stated in this brief, promoting later marriage, to at least age 18, and shoring up protection options within marriage may be essential means of stemming the epidemic.
APA, Harvard, Vancouver, ISO, and other styles
8

Hay, M. S., C. J. Coleman, and D. P. Diprete. Analysis of tank 38H (HTF-38-17-18, -19) and tank 43H (HTF-43-17-20, -21) samples for support of the enrichment control and corrosion control programs. Office of Scientific and Technical Information (OSTI), March 2017. http://dx.doi.org/10.2172/1351955.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hay, M. S., C. J. Coleman, and D. P. Diprete. Analysis of Tank 38H (HTF-38-19-18, -19) and Tank 43H (HTF-43-19-20, -21) Samples for Support of the Enrichment Control and Corrosion Control Programs. Office of Scientific and Technical Information (OSTI), May 2019. http://dx.doi.org/10.2172/1519111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lazdane, Gunta, Dace Rezeberga, Ieva Briedite, Inara Kantane, Elizabete Pumpure, Ieva Pitkevica, Darja Mihailova, and Marta Laura Gravina. Sexual and reproductive health survey in the time of COVID-19 – Latvia, 2020. Rīga Stradiņš University, February 2021. http://dx.doi.org/10.25143/fk2/j5kxxd.

Full text
Abstract:
The results of the anonymous online survey of people living in Latvia age 18 and over, using internationally (I-SHARE) and nationally validated questionnaire. Data include following variables: Selection, socio-demographics, social distancing measures, couple and family relationships, sexual behavior, access to condoms and contraceptives, access to reproductive health services, antenatal care, pregnancy and maternal and child health, abortion, sexual and gender-based violence, HIV/STI, mental health, and nutrition. (2021-02-08)
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'HTV 18' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography